HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figure All Versions of this Article: 291/5/C817    most recent 00198.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Herring, B. P. Articles by Zhou, J. Search for Related Content PubMed PubMed Citation Articles by Herring, B. P. Articles by Zhou, J.

INVITED REVIEW

Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues

Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana

The mylk1 gene is a large gene spanning 250 kb and comprising at least 31 exons. The mylk1 gene encodes at least four protein products: two isoforms of the 220-kDa myosin light chain kinase (MLCK), a 130-kDa MLCK, and telokin. Transcripts encoding these products are derived from four independent promoters within the mylk1 gene. The kinases expressed from the mylk1 gene have been extensively characterized and function to regulate the activity of nonmuscle and smooth muscle myosin II. Activation of these myosin motors by MLCK modulates a variety of contractile processes, including smooth muscle contraction, cell adhesion, migration, and proliferation. Dysregulation of these processes contributes to a number of diseases. The noncatalytic gene product telokin also has been shown to modulate contraction in smooth muscle cells through its ability to inhibit myosin light chain phosphatase. Given the crucial role of the products of the mylk1 gene in regulating numerous contractile processes, it seems intuitive that alterations in the transcriptional activity of the mylk1 gene also will have a significant impact on many physiological and pathological processes. In this review we highlight some of the recent studies that have described the transcriptional regulation of mylk1 gene products in smooth muscle tissues and discuss the implications of these findings for regulation of expression of other smooth muscle-specific genes.

myocardin; serum response factor; GATA; gene expression; Hox genes

This article has been cited by other articles:

				C. P. Gayer, L. S. Chaturvedi, S. Wang, B. Alston, T. L. Flanigan, and M. D. Basson Delineating the signals by which repetitive deformation stimulates intestinal epithelial migration across fibronectin Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G876 - G885. [Abstract] [Full Text] [PDF]

				J. A. Madden, M. W. Dantuma, E. A. Sorokina, D. Weihrauch, and J. G. Kleinman Telokin expression and the effect of hypoxia on its phosphorylation status in smooth muscle cells from small and large pulmonary arteries Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1166 - L1173. [Abstract] [Full Text] [PDF]

				K. Touw, A. M. Hoggatt, G. Simon, and B. P. Herring Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1024 - C1032. [Abstract] [Full Text] [PDF]